+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dissolvable Microneedle Patches Market - Global Forecast 2026-2032- Product Image
Dissolvable Microneedle Patches Market - Global Forecast 2026-2032- Product Image
Sale

Dissolvable Microneedle Patches Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6084744
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Dissolvable Microneedle Patches Market is projected to reach USD 629.79 Million in 2026. It is expected to continue growing at a CAGR of 18.83%, reaching USD 1.78 Billion by 2032.

Dissolvable Microneedle Patches: Executive Overview

Dissolvable microneedle patches are minimally invasive delivery platforms that use micron-scale projections to deposit active ingredients into or across the skin, where the structures dissolve or disintegrate. Their potential value lies in needle-free handling, localized delivery, reduced sharps waste, and suitability for self-administration. Adoption remains dependent on reliable manufacturing, consistent dose delivery, product stability, regulatory classification, and evidence of clinical benefit.

Manufacturing and Regulatory Forces Are Reshaping Adoption

The field is shifting from laboratory demonstration toward reproducible product development. Key priorities include uniform microneedle geometry, scalable molding or printing processes, moisture protection, packaging integrity, skin-application performance, and quality control for dose uniformity. Regulatory pathways may differ according to whether a patch is positioned as a drug, vaccine, medical device, cosmetic, or combination product, making early classification and evidence planning essential. Patient convenience, reduced dependence on trained personnel, and interest in self-administered therapies are supporting development, while reimbursement, shelf-life validation, and manufacturing economics remain important constraints.

Artificial Intelligence Accelerates Design, Testing, and Quality Management

Artificial intelligence can support dissolvable microneedle development by analyzing formulation variables, polymer behavior, geometry, insertion performance, dissolution profiles, and skin-response data. Machine-learning models may help prioritize experiments and identify relationships that are difficult to detect with conventional trial-and-error methods. In manufacturing, computer vision and anomaly detection can assist with inspection of patch dimensions, defects, and packaging. These applications require validated datasets, interpretable models, cybersecurity controls, and human oversight because model outputs do not replace analytical, toxicological, or clinical evidence.

Regional Priorities Differ Across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific

North America is characterized by strong biomedical research capacity, advanced combination-product development, and emphasis on clinical and regulatory validation. Europe places particular importance on harmonized quality systems, patient safety, sustainability, and access considerations across national health systems. Asia-Pacific combines substantial manufacturing capabilities with large and diverse healthcare needs, making scalable production and temperature-resilient delivery especially relevant. Latin America is likely to prioritize affordability, distribution practicality, and compatibility with public-health delivery models. The Middle East is emphasizing healthcare modernization, specialized clinical infrastructure, and technology-enabled care, while Africa presents significant opportunities for thermostable, easy-to-administer products but requires attention to supply chains, local manufacturing, training, and equitable access.

ASEAN, BRICS, the European Union, G7, GCC, and NATO Reflect Distinct Strategic Needs

ASEAN markets may benefit from products suited to varied climates, decentralized care, and expanding digital-health ecosystems. BRICS countries represent diverse regulatory, manufacturing, and public-health environments, creating opportunities for localized production and differentiated access strategies. The European Union emphasizes common regulatory principles alongside national reimbursement decisions. G7 economies generally have strong research, quality, and clinical infrastructure but demand rigorous evidence and clear value propositions. GCC countries are investing in healthcare modernization and may favor specialized, high-quality delivery technologies, while NATO members may also consider supply resilience, emergency preparedness, and dependable access to essential medical products. These groupings should be treated as heterogeneous rather than as uniform commercial or regulatory blocs.

Country Conditions Shape Clinical Translation and Commercial Readiness

Australia offers advanced clinical research and geographically dispersed-care use cases. Brazil and Mexico require attention to affordability, regulatory navigation, and distribution across varied healthcare settings. Canada emphasizes evidence, safety, and access across a large geography. China, India, Japan, and South Korea combine strong technical capabilities with distinct regulatory, reimbursement, and manufacturing considerations. France, Germany, Italy, Spain, and the United Kingdom require alignment with European quality expectations and country-specific procurement or reimbursement systems. Russia presents a separate regulatory and supply-chain environment requiring careful assessment of local requirements. Across the United States, clinical evidence, combination-product classification, manufacturing controls, and payer relevance are central to adoption.

Industry Leaders Should Prioritize Evidence, Manufacturability, and Access

Leaders should select target applications where reduced pain, simpler administration, storage advantages, or improved adherence can be demonstrated clearly. Development programs should integrate formulation science, device engineering, human-factors testing, analytical validation, and clinical planning from the outset. Companies should establish design controls, moisture and packaging strategies, supplier qualification, and inspection systems before scale-up. Regulatory consultations can clarify product classification and evidence expectations early. Partnerships with local health systems, contract manufacturers, and public-health organizations can improve regional fit. Finally, teams should use artificial intelligence selectively, with validated data governance and documented human review, while building access plans around affordability, training, distribution, and end-of-life waste management.

Research Methodology for Assessing Dissolvable Microneedle Patches

This executive summary uses a structured qualitative assessment of the dissolvable microneedle patch technology landscape. The framework reviews product mechanisms, materials and formulation considerations, manufacturing readiness, regulatory themes, clinical-use requirements, artificial-intelligence applications, sustainability factors, and healthcare-delivery conditions. Regional, group, and country perspectives are organized around research capacity, manufacturing, regulation, infrastructure, access, and implementation practicality. No market estimates, market shares, forecasts, or company-specific claims are used. Conclusions should be validated against current peer-reviewed evidence, official regulatory publications, clinical-trial records, and country-level healthcare policies before investment or product decisions.

Dissolvable Microneedle Patches Require Coordinated Scientific and Health-System Execution

Dissolvable microneedle patches offer a promising route toward less invasive, potentially self-administered delivery, but technical novelty alone will not ensure adoption. Progress depends on reproducible dose performance, robust stability, clear regulatory positioning, clinically meaningful outcomes, manufacturability, and integration with real-world care pathways. Regional and country differences make adaptable development and access strategies essential. The strongest programs will connect materials science and intelligent quality systems with rigorous evidence, patient-centered design, resilient supply chains, and practical implementation planning.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Dissolvable Microneedle Patches Market, by Polymer Type
7.1. Introduction
7.2. Chitosan
7.3. Hyaluronic Acid
7.4. Polylactic Acid
7.5. Polyvinylpyrrolidone
8. Dissolvable Microneedle Patches Market, by Application
8.1. Introduction
8.2. Cosmetic
8.3. Pharmaceutical
8.3.1. Analgesic
8.3.2. Insulin
8.3.3. Vaccine
9. Dissolvable Microneedle Patches Market, by End User
9.1. Introduction
9.2. Clinics
9.3. Home Healthcare
9.4. Hospitals
9.5. Research Laboratories
10. Dissolvable Microneedle Patches Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
11. Dissolvable Microneedle Patches Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Dissolvable Microneedle Patches Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Dissolvable Microneedle Patches Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. 111Skin
15.2. 3M Company
15.3. AdminMed, Inc.
15.4. AND SHINE
15.5. Beijing CAS Microneedle Technology
15.6. Corium, Inc.
15.7. CosMED Pharmaceutical Co., Ltd.
15.8. ESK GmbH
15.9. Hero Cosmetics
15.10. Kindeva Drug Delivery
15.11. LTS Lohmann Therapie-Systeme AG
15.12. Micron Biomedical Inc.
15.13. Microneedle Biosystems NV
15.14. Micropoint Technologies
15.15. NanoPass Technology Ltd.
15.16. Nissha Co., Ltd.
15.17. Rani Therapeutics LLC
15.18. Raphas Co., Ltd.
15.19. Shiseido Company, Limited
15.20. Skyn Iceland
15.21. Vaxess Technologies, Inc.
15.22. Zhuhai Youwe Biotechnology
15.23. Zosano Pharma Corp.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Dissolvable Microneedle Patches Market, Years Considered for the Study
FIGURE 2. Global Dissolvable Microneedle Patches Market, Research Design
FIGURE 3. Global Dissolvable Microneedle Patches Market, Research Framework
FIGURE 4. Global Dissolvable Microneedle Patches Market, Data Triangulation
FIGURE 5. Global Dissolvable Microneedle Patches Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Dissolvable Microneedle Patches Market Size, by Polymer Type, 2025 vs 2032 (%)
FIGURE 7. Global Dissolvable Microneedle Patches Market Size, by Polymer Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Dissolvable Microneedle Patches Market Size, by Application, 2025 vs 2032 (%)
FIGURE 9. Global Dissolvable Microneedle Patches Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Dissolvable Microneedle Patches Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Dissolvable Microneedle Patches Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Dissolvable Microneedle Patches Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Dissolvable Microneedle Patches Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Dissolvable Microneedle Patches Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Dissolvable Microneedle Patches Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Dissolvable Microneedle Patches Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Dissolvable Microneedle Patches Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Dissolvable Microneedle Patches Market Segmentation & Coverage
TABLE 2. Global Dissolvable Microneedle Patches Market Size, 2017-2032 (USD Million)
TABLE 3. Global Dissolvable Microneedle Patches Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 4. Global Chitosan Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Chitosan Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Chitosan Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Hyaluronic Acid Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Hyaluronic Acid Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Hyaluronic Acid Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Polylactic Acid Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Polylactic Acid Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Polylactic Acid Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Polyvinylpyrrolidone Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Polyvinylpyrrolidone Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Polyvinylpyrrolidone Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Dissolvable Microneedle Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 17. Global Cosmetic Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Cosmetic Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Cosmetic Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Pharmaceutical Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Pharmaceutical Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Pharmaceutical Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Analgesic Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Analgesic Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Analgesic Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Insulin Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Insulin Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Insulin Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Dissolvable Microneedle Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 33. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Home Healthcare Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Home Healthcare Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Home Healthcare Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Research Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Research Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Research Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 46. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Dissolvable Microneedle Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Asia-Pacific Dissolvable Microneedle Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Asia-Pacific Dissolvable Microneedle Patches Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 58. Asia-Pacific Dissolvable Microneedle Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific Dissolvable Microneedle Patches Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Dissolvable Microneedle Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 62. North America Dissolvable Microneedle Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. North America Dissolvable Microneedle Patches Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 64. North America Dissolvable Microneedle Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 65. North America Dissolvable Microneedle Patches Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 66. North America Dissolvable Microneedle Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 67. North America Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 68. Latin America Dissolvable Microneedle Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Latin America Dissolvable Microneedle Patches Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 70. Latin America Dissolvable Microneedle Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 71. Latin America Dissolvable Microneedle Patches Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 72. Latin America Dissolvable Microneedle Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 73. Latin America Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 74. Europe Dissolvable Microneedle Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Europe Dissolvable Microneedle Patches Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 76. Europe Dissolvable Microneedle Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 77. Europe Dissolvable Microneedle Patches Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 78. Europe Dissolvable Microneedle Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 79. Europe Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 80. Middle East Dissolvable Microneedle Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Middle East Dissolvable Microneedle Patches Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 82. Middle East Dissolvable Microneedle Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 83. Middle East Dissolvable Microneedle Patches Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 84. Middle East Dissolvable Microneedle Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 85. Middle East Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 86. Africa Dissolvable Microneedle Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Africa Dissolvable Microneedle Patches Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 88. Africa Dissolvable Microneedle Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 89. Africa Dissolvable Microneedle Patches Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 90. Africa Dissolvable Microneedle Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 91. Africa Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 92. Global Dissolvable Microneedle Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. ASEAN Dissolvable Microneedle Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. ASEAN Dissolvable Microneedle Patches Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 95. ASEAN Dissolvable Microneedle Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 96. ASEAN Dissolvable Microneedle Patches Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 97. ASEAN Dissolvable Microneedle Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 98. ASEAN Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 99. GCC Dissolvable Microneedle Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. GCC Dissolvable Microneedle Patches Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 101. GCC Dissolvable Microneedle Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 102. GCC Dissolvable Microneedle Patches Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 103. GCC Dissolvable Microneedle Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. GCC Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 105. European Union Dissolvable Microneedle Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. European Union Dissolvable Microneedle Patches Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 107. European Union Dissolvable Microneedle Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 108. European Union Dissolvable Microneedle Patches Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 109. European Union Dissolvable Microneedle Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 110. European Union Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 111. BRICS Dissolvable Microneedle Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. BRICS Dissolvable Microneedle Patches Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 113. BRICS Dissolvable Microneedle Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 114. BRICS Dissolvable Microneedle Patches Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 115. BRICS Dissolvable Microneedle Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 116. BRICS Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 117. G7 Dissolvable Microneedle Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. G7 Dissolvable Microneedle Patches Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 119. G7 Dissolvable Microneedle Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 120. G7 Dissolvable Microneedle Patches Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 121. G7 Dissolvable Microneedle Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. G7 Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 123. NATO Dissolvable Microneedle Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. NATO Dissolvable Microneedle Patches Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 125. NATO Dissolvable Microneedle Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 126. NATO Dissolvable Microneedle Patches Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 127. NATO Dissolvable Microneedle Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. NATO Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 129. Global Dissolvable Microneedle Patches Market Size, by Country, 2017-2032 (USD Million)
TABLE 130. United States Dissolvable Microneedle Patches Market Size, 2017-2032 (USD Million)
TABLE 131. United States Dissolvable Microneedle Patches Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 132. United States Dissolvable Microneedle Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 133. United States Dissolvable Microneedle Patches Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 134. United States Dissolvable Microneedle Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 135. United States Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 136. Canada Dissolvable Microneedle Patches Market Size, 2017-2032 (USD Million)
TABLE 137. Canada Dissolvable Microneedle Patches Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 138. Canada Dissolvable Microneedle Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 139. Canada Dissolvable Microneedle Patches Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 140. Canada Dissolvable Microneedle Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 141. Canada Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 142. Mexico Dissolvable Microneedle Patches Market Size, 2017-2032 (USD Million)
TABLE 143. Mexico Dissolvable Microneedle Patches Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 144. Mexico Dissolvable Microneedle Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 145. Mexico Dissolvable Microneedle Patches Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 146. Mexico Dissolvable Microneedle Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. Mexico Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 148. Brazil Dissolvable Microneedle Patches Market Size, 2017-2032 (USD Million)
TABLE 149. Brazil Dissolvable Microneedle Patches Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 150. Brazil Dissolvable Microneedle Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 151. Brazil Dissolvable Microneedle Patches Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 152. Brazil Dissolvable Microneedle Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 153. Brazil Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 154. United Kingdom Dissolvable Microneedle Patches Market Size, 2017-2032 (USD Million)
TABLE 155. United Kingdom Dissolvable Microneedle Patches Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 156. United Kingdom Dissolvable Microneedle Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 157. United Kingdom Dissolvable Microneedle Patches Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 158. United Kingdom Dissolvable Microneedle Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. United Kingdom Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 160. Germany Dissolvable Microneedle Patches Market Size, 2017-2032 (USD Million)
TABLE 161. Germany Dissolvable Microneedle Patches Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 162. Germany Dissolvable Microneedle Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 163. Germany Dissolvable Microneedle Patches Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 164. Germany Dissolvable Microneedle Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. Germany Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 166. France Dissolvable Microneedle Patches Market Size, 2017-2032 (USD Million)
TABLE 167. France Dissolvable Microneedle Patches Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 168. France Dissolvable Microneedle Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 169. France Dissolvable Microneedle Patches Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 170. France Dissolvable Microneedle Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 171. France Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 172. Russia Dissolvable Microneedle Patches Market Size, 2017-2032 (USD Million)
TABLE 173. Russia Dissolvable Microneedle Patches Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 174. Russia Dissolvable Microneedle Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 175. Russia Dissolvable Microneedle Patches Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 176. Russia Dissolvable Microneedle Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 177. Russia Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 178. Italy Dissolvable Microneedle Patches Market Size, 2017-2032 (USD Million)
TABLE 179. Italy Dissolvable Microneedle Patches Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 180. Italy Dissolvable Microneedle Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 181. Italy Dissolvable Microneedle Patches Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 182. Italy Dissolvable Microneedle Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 183. Italy Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 184. Spain Dissolvable Microneedle Patches Market Size, 2017-2032 (USD Million)
TABLE 185. Spain Dissolvable Microneedle Patches Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 186. Spain Dissolvable Microneedle Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 187. Spain Dissolvable Microneedle Patches Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 188. Spain Dissolvable Microneedle Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. Spain Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 190. China Dissolvable Microneedle Patches Market Size, 2017-2032 (USD Million)
TABLE 191. China Dissolvable Microneedle Patches Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 192. China Dissolvable Microneedle Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 193. China Dissolvable Microneedle Patches Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 194. China Dissolvable Microneedle Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. China Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 196. India Dissolvable Microneedle Patches Market Size, 2017-2032 (USD Million)
TABLE 197. India Dissolvable Microneedle Patches Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 198. India Dissolvable Microneedle Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. India Dissolvable Microneedle Patches Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 200. India Dissolvable Microneedle Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 201. India Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 202. Japan Dissolvable Microneedle Patches Market Size, 2017-2032 (USD Million)
TABLE 203. Japan Dissolvable Microneedle Patches Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 204. Japan Dissolvable Microneedle Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 205. Japan Dissolvable Microneedle Patches Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 206. Japan Dissolvable Microneedle Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 207. Japan Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 208. Australia Dissolvable Microneedle Patches Market Size, 2017-2032 (USD Million)
TABLE 209. Australia Dissolvable Microneedle Patches Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 210. Australia Dissolvable Microneedle Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 211. Australia Dissolvable Microneedle Patches Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 212. Australia Dissolvable Microneedle Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. Australia Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 214. South Korea Dissolvable Microneedle Patches Market Size, 2017-2032 (USD Million)
TABLE 215. South Korea Dissolvable Microneedle Patches Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 216. South Korea Dissolvable Microneedle Patches Market Size, by Application, 2017-2032 (USD Million)
TABLE 217. South Korea Dissolvable Microneedle Patches Market Size, by Pharmaceutical, 2017-2032 (USD Million)
TABLE 218. South Korea Dissolvable Microneedle Patches Market Size, by End User, 2017-2032 (USD Million)
TABLE 219. South Korea Dissolvable Microneedle Patches Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 220. Global Dissolvable Microneedle Patches Market Share, by Key Player, 2025
TABLE 221. Global Dissolvable Microneedle Patches Market, Key Experts

Companies Mentioned

  • 111Skin
  • 3M Company
  • AdminMed, Inc.
  • AND SHINE
  • Beijing CAS Microneedle Technology
  • Corium, Inc.
  • CosMED Pharmaceutical Co., Ltd.
  • ESK GmbH
  • Hero Cosmetics
  • Kindeva Drug Delivery
  • LTS Lohmann Therapie-Systeme AG
  • Micron Biomedical Inc.
  • Microneedle Biosystems NV
  • Micropoint Technologies
  • NanoPass Technology Ltd.
  • Nissha Co., Ltd.
  • Rani Therapeutics LLC
  • Raphas Co., Ltd.
  • Shiseido Company, Limited
  • Skyn Iceland
  • Vaxess Technologies, Inc.
  • Zhuhai Youwe Biotechnology
  • Zosano Pharma Corp.

Related Topics

Related Reports

Microneedle Skincare Patches Market - Global Forecast 2026-2032 - Product Image

Microneedle Skincare Patches Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Drug Microneedle Patches Market - Global Forecast 2026-2032 - Product Image

Drug Microneedle Patches Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Microneedle Patches Market Insights, Competitive Landscape, and Market Forecast - 2033 - Product Image

Microneedle Patches Market Insights, Competitive Landscape, and Market Forecast - 2033

  • Report
  • 191 Pages
  • Global
From
Microneedle Patches Market Outlook 2026-2034: Market Share and Growth Analysis by Product Type, Application, End User, Material - Product Image

Microneedle Patches Market Outlook 2026-2034: Market Share and Growth Analysis by Product Type, Application, End User, Material

  • Report
  • 160 Pages
  • Global
From
Microneedle Patches Market - Global Strategic Business Report - Product Image

Microneedle Patches Market - Global Strategic Business Report

  • Report
  • 290 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.